Hormone replacement therapy (HRT) does not increase breast cancer risk in BRCA1/BRCA2 carriers, with estrogen-alone formulations showing a lower risk. The study used a matched-pair design to control ...
Welcome back to our series of articles sponsored by Intel – “Ask a Data Scientist.” Once a week you’ll see reader submitted questions of varying levels of technical detail answered by a practicing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback